• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Zomedica Corp. (ZOM) Stock Price, News & Analysis

Zomedica Corp. (ZOM) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.13

-$0

(-0.99%)

Day's range
$0.13
Day's range
$0.14
50-day range
$0.117
Day's range
$0.1548
  • Country: US
  • ISIN: CA98980M1095
52 wk range
$0.12
Day's range
$0.23


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 4.98
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (ZOM)
  • Company Zomedica Corp.
  • Price $0.13
  • Changes Percentage (-0.99%)
  • Change -$0
  • Day Low $0.13
  • Day High $0.14
  • Year High $0.23

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/04/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.04
  • Trailing P/E Ratio -3.71
  • Forward P/E Ratio -3.71
  • P/E Growth -3.71
  • Net Income $-34,529,000

Income Statement

Quarterly

Annual

Latest News of ZOM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Zomedica Corp. Frequently Asked Questions

  • What is the Zomedica Corp. stock price today?

    Today's price of Zomedica Corp. is $0.13 — it has decreased by -0.99% in the past 24 hours. Watch Zomedica Corp. stock price performance more closely on the chart.

  • Does Zomedica Corp. release reports?

    Yes, you can track Zomedica Corp.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Zomedica Corp. stock forecast?

    Watch the Zomedica Corp. chart and read a more detailed Zomedica Corp. stock forecast to see what analysts suggest you do with its shares.

  • What is Zomedica Corp. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by Zomedica Corp. stock ticker.

  • How to buy Zomedica Corp. stocks?

    Like other stocks, ZOM shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Zomedica Corp.'s EBITDA?

    Zomedica Corp. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Zomedica Corp.’s financial statements.

  • What is the Zomedica Corp.'s net income ratio for the financial year 2024?

    The net income ratio for the financial year 2024 is -1.3709600572, which equates to approximately -137.10%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Zomedica Corp. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Zomedica Corp.'s financials relevant news, and technical analysis. Zomedica Corp.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Zomedica Corp. stock currently indicates a “sell” signal. For more insights, review Zomedica Corp.’s technical analysis.

  • A revenue figure for Zomedica Corp. for its last quarter?

    Zomedica Corp. published it's last quarterly revenues at $7.00 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.